AGTC Shares Outstanding History
Below is a table of the AGTC shares outstanding history going back to 3/27/2014:

Date AGTC Shares Outstanding
3/27/201412.80M
5/8/201414.08M
9/19/201416.39M
10/31/201416.41M
1/30/201516.44M
4/30/201516.48M
8/31/201517.95M
10/30/201518.00M
2/1/201618.04M
5/2/201618.04M
8/31/201618.05M
10/18/201618.06M
10/31/201618.07M
2/3/201718.08M
5/5/201718.08M
8/31/201718.09M
10/15/201718.09M
10/31/201718.09M
2/3/201818.10M
5/2/201818.11M
8/31/201818.13M
10/31/201818.13M
2/7/201918.17M
4/30/201918.17M
9/24/201918.22M
7/18/201969.94M
11/8/201918.22M
2/4/202018.28M
5/8/202025.77M
9/2/202025.86M
11/11/202025.89M
2/4/202142.66M
5/13/202142.75M
9/16/202142.86M
11/4/202142.86M
2/9/202242.92M
5/12/202250.73M
9/21/202267.63M
10/21/202267.63M

Also see: AGTC Market Cap History
AGTC YTD Return
AGTC Historical Shares Outstanding:
+21.42% CAGR
AGTC Historical Shares Outstanding: +21.42% CAGR

Mouse over chart for data details
3/27/2014 ...10/21/2022
Applied Genetic Technologies is a clinical-stage biotechnology company that uses a proprietary gene therapy platform to develop transformational genetic therapies for people suffering from rare and debilitating diseases. Co.'s initial focus is in the field of ophthalmology, where it has wholly owned clinical-stage programs in X-linked retinitis pigmentosa and achromatopsia, and an optogenetics program. Co.'s preclinical pipeline includes a program in dry age-related macular degeneration, two programs targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis, and a program in otology through its collaboration with Otonomy, Inc. We show 39 historical shares outstanding datapoints in our coverage of AGTC's shares outstanding history.

Understanding the changing numbers of AGTC shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like AGTC versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching AGTC by allowing them to research AGTC shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree AGTC Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Applied Genetic Technologies (AGTC) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

AGTI Shares Outstanding History
AHCO Shares Outstanding History
AHPI Shares Outstanding History
AIKI Shares Outstanding History
AIMT Shares Outstanding History
AIPT Shares Outstanding History
AIQ Shares Outstanding History
AITB Shares Outstanding History
AKAO Shares Outstanding History
AKBA Shares Outstanding History
More Healthcare companies »

 

AGTC Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.